Gilberto Perez Rodriguez Garcia

Gilberto Perez Rodriguez Garcia


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 November 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
GGGilberto Perez Rodriguez Garcia
Gilberto Perez Rodriguez Garcia
EMErik Middlebrooks
Erik Middlebrooks
SMShanshan Mei
Shanshan Mei
TTTakashi Tsuboi
Takashi Tsuboi
JWJoshua Wong
Joshua Wong
Adolfo Ramirez-ZamoraAdolfo Ramirez-Zamora
Adolfo Ramirez-Zamora
Background/Objectives: Deep brain stimulation (DBS) of the globus pallidus interna (GPi) is a safe and established therapy for management of refractory motor fluctuations and dyskinesia in Parkinson’s disease (PD). However, the relationship between stimulation site connectivity and improvement of axial gait symptoms remains poorly understood, particularly when stimulating in the GPi. This study investigated functional and structural connectivity patterns specifically associated with axial symptom outcomes following bilateral GPi-DBS, and, as a secondary exploratory analysis, examined whether Volumes of tissue activated (VTAs)-based connectivity related to overall UPDRS-III change. Methods: We retrospectively analyzed 19 PD patients who underwent bilateral GPi-DBS at the University of Florida (2002–2017). Unified Parkinson’s Disease Rating Scale (UPDRS-III) axial gait subscores were assessed at baseline and 36-month follow-up. VTAs were reconstructed using Lead-DBS and coregistered to Montreal Neurological Institute (MNI) space. Structural connectivity was evaluated with diffusion tractography, and functional connectivity was estimated using normative resting-state fMRI datasets. Correlations between VTA connectivity and clinical improvement were examined using Spearman correlation and voxelwise analyses. Results: Patients with axial improvement in motor scales demonstrated specific VTA connectivity to sensorimotor and supplementary motor networks, particularly lobule V and lobules I–IV of the cerebellum. These associations were specific to axial gait subscores. In contrast, worsening axial gait symptoms correlated with connectivity to cerebellar Crus II, cerebellum VIII, calcarine cortex, and thalamus (p < 0.05). Total UPDRS-III scores did not show a significant positive correlation with supplementary motor area or primary motor cortex connectivity; a non-significant trend was observed for VTA–M1 connectivity (R = 0.41, p = 0.078). Worsening total motor scores were associated with cerebellar Crus II and frontal–parietal networks. These findings suggest that distinct connectivity patterns underlie differential trajectories in axial and global motor outcomes following GPi-DBS. Conclusions: Distinct connectivity profiles might underlie axial gait symptom outcomes following GPi-DBS. Connectivity to motor and sensorimotor pathways supports improvement, whereas involvement of Crus II and occipital networks predicts worsening. Additional studies to confirm and expand on these findings are needed, but our results highlight the value of connectomic mapping for refining patient-specific targeting and developing future programming strategies.

23 September 2025 in Endocrine Practice
Verified
Journal Article
Closed access
SBSharon Bridgemohan
Sharon Bridgemohan
AOAndrea Ortiz
Andrea Ortiz
GGGilberto Perez Rodriguez Garcia
Gilberto Perez Rodriguez Garcia
SKSannidhi Kolukula
Sannidhi Kolukula
GAGonzalo J. Acosta
Gonzalo J. Acosta
NONaykky Singh Ospina
Naykky Singh Ospina

24 October 2025 in The Journal of Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
SHSaad Habib
Saad Habib
GGGilberto Perez Rodriguez Garcia
Gilberto Perez Rodriguez Garcia
ZZZhongyue Zhang
Zhongyue Zhang
ARArkaprava Roy
Arkaprava Roy
Yonghui WuYonghui Wu
Yonghui Wu
NONaykky Singh Ospina
Naykky Singh Ospina
Context: Thyroid nodules are common in clinical practice, and inappropriate selection of patients for thyroid biopsy can contribute to thyroid cancer overdiagnosis or delayed diagnosis. Objective: This work aimed to evaluate the frequency of inappropriate thyroid biopsies in practice, following a framework that integrates thyroid nodule ultrasound (US) features and patient-specific clinical factors. Methods: This cross-sectional study was conducted at a single academic center in the United States. Participants included adult patients who underwent their first thyroid fine-needle aspiration (FNA) biopsy between January 1, 2016, and December 31, 2023, at the University of Florida. Data collection included thyroid US characteristics, clinical factors (eg, comorbidities, patient preferences), and context for biopsy decision-making. Main outcome measures included the appropriateness of thyroid biopsy assessed using a tiered framework incorporating US features and additional clinical factors. Results: A total of 899 patients were evaluated, with 441 meeting the inclusion criteria and undergoing 481 thyroid biopsies. Of these, 388 of 481 (80.7%) were classified as likely appropriate (L-APP) based on the American College of Radiology Thyroid Imaging Reporting and Data System criteria. In 34 of 481 (7%) of cases, clinical factors such as thyroid cancer risk features, comorbidities, symptoms, or patient preferences led to reclassification from likely inappropriate (L-INAP) to L-APP. In 50 of 481 (10%) of cases, limited life expectancy (eg, chemotherapy, end-stage disease) led to reclassification from L-APP to possibly or extremely inappropriate (EXT-INAP). EXT-INAP biopsies occurred in only 0.8% (4/481) of cases. Conclusion: This study underscores the value of integrating US findings with clinical context to guide thyroid biopsy decisions and enhance patient-centered care.

16 March 2026 in Neurosurgical Review
Verified
Journal Article
Closed access
GGGilberto Perez Rodriguez Garcia
Gilberto Perez Rodriguez Garcia
AAAbdulwhab Alotaibi
Abdulwhab Alotaibi
OYOmid Yousefi
Omid Yousefi
Ataollah ShahbandiAtaollah Shahbandi
Ataollah Shahbandi
PGPegah Ghamasaee
Pegah Ghamasaee
MBMohamad Bakhaidar
Mohamad Bakhaidar

1 June 2026 in Neurology Clinical Practice
Verified
Journal Article
Closed access
GHGrace Elaine Hey
Grace Elaine Hey
HKHikaru Kamo
Hikaru Kamo
GGGilberto Perez Rodriguez Garcia
Gilberto Perez Rodriguez Garcia
TMTejas R. Mehta
Tejas R. Mehta
RERobert Stephen Eisinger
Robert Stephen Eisinger
Adolfo Ramirez-ZamoraAdolfo Ramirez-Zamora
Adolfo Ramirez-Zamora
Patients with young-onset Parkinson disease (YOPD) commonly experience early motor complications necessitating deep brain stimulation (DBS), and the subthalamic nucleus (STN) and globus pallidus interna (GPi) are the primary DBS targets used for reducing medication use and addressing dyskinesias. This study leveraged both the University of Florida Fixel Institute high volume of DBS operations and the INFORM database to evaluate motor outcomes in a large cohort of patients with YOPD treated with STN or GPi DBS, and addressed the limited available evidence and paucity of data on the long-term effects of these targets applied to YOPD. A single-center retrospective chart review was conducted on a nonrandomized cohort of adult patients with a diagnosis of YOPD treated with STN or GPi DBS between January 1999 and October 2023. Multidisciplinary evaluation was used to choose the anatomical target for each patient. Disease onset, lead location, medications, and mortality were collected and compared between cohorts. Preoperative, 6-month, and 1-, 3-, and 5-year Unified Parkinson's Disease Rating Scale (UPDRS) scores were used to compare motor outcomes. There were 405 patients, and 61.3% received GPi DBS and 37.7% STN DBS. Mean disease duration at surgery was 12.3 (4.2) years for GPi and 11.5 (6.3) years for STN. GPi DBS improved ON UPDRS part 3 scores at 1 year (26.5 [11.84] vs 20.94 [9.09], p = 0.0024), and these scores worsened slightly by 5-year follow-up (20.94 [9.09] vs 24.72 [10.28], p = 0.0491). Unilateral STN DBS showed greater 6-month motor improvement vs unilateral GPi (p < 0.001) and remained stable from 6 months to 3 years (p = 0.3). GPi DBS improved ON UPDRS part 4 scores from baseline to 5 years (8.34 [3.15] vs 4.21 [2.25], p < 0.0001), whereas STN DBS showed no significant change (6.16 [4.21] vs 5.0 [2.98], p = 0.328). Although statistically significant, the changes did not meet the threshold for clinical relevance. This large cohort study assessed long-term outcomes of STN vs GPi DBS when used in the setting of YOPD. Both targets improved motor symptoms at 1 and 5 years. STN offered modest motor benefits and greater medication reduction, while GPi DBS better addressed dyskinesia and motor fluctuations. These findings inform preoperative decision-making, although selection bias based on baseline symptoms remains a limitation of the data set.

4 April 2026 in European Spine Journal
Verified
Journal Article
Closed access
GGGilberto Perez Rodriguez Garcia
Gilberto Perez Rodriguez Garcia
JKJames Kelbert
James Kelbert
DSDana Saleh
Dana Saleh
APAnnemarie Pico
Annemarie Pico
NDNikhil Dholaria
Nikhil Dholaria
ABAli A. Baaj
Ali A. Baaj